06/12/2018 18:01:00

Honolulu Ophthalmologist Implants First Visian® Toric ICL in Hawaii

HONOLULU, Dec. 06, 2018 (GLOBE NEWSWIRE) -- On December 17, 2018 Honolulu ophthalmologist and experienced eye surgeon Alan Faulkner, MD, performed the first surgical implantation of the Visian Toric ICL (TICL) on the Hawaiian islands. Dr. Faulkner explains this important milestone marks a significant advancement in the field of vision correction, and broadens the scope of candidates at Aloha Laser Vision that can be helped with ICL technology. Surgery to implant the standard Visian ICL—approved by the FDA in 2005—is only a suitable option for patients with myopia; however, the innovation of the TICL now allows for the correction of astigmatism as well.

The Visian Toric ICL is an Implantable Collamer® Lens (ICL) designed specifically to correct for myopic astigmatism (nearsightedness and astigmatism), which is caused by imperfections in the curvature of the lens or an irregularly shaped cornea. On September 13, 2018 the Visian TICL received FDA-approval, and Dr. Faulkner is among the first wave of ophthalmologists in the United States who have moved forward with implanting the TICL in patients. In STAAR’s clinical trials, TICL implantation produced excellent long-term treatment results—“with 94.6% of patients reporting excellent or very good vision quality.”

Dr. Faulkner says that patients with myopia and astigmatism who are not good candidates for laser vision correction procedures (i.e. LASIK and PRK)—often those with thin corneas or dry eyes—can consider implantation of the TICL to achieve better sight and reduce reliance on contacts and glasses. The TICL is implanted during a 20 to 30 minute procedure as a secondary lens, which is able to provide the specific degree of vision correction the patient needs. This means the cornea does not have to be reshaped or replaced, and the procedure is completely reversible. The new TICL also saves time for vision correction patients with myopic astigmatism who frequently require multiple procedures (with other methods) to achieve excellent vision.

As advancements in vision correction like the TICL continue to emerge, Dr. Faulkner and his team remain committed to adopting these new techniques and technologies to provide their patients with state-of-the-art care.

About Alan Faulkner, MD

Dr. Faulkner

is board-certified by the American Board of Ophthalmology, and the lead eye surgeon at Aloha Laser Vision. Since 2001 he has expanded his practice into a state-of-the-art laser vision correction center offering a broad spectrum of premium services, including LASIK, cataract surgery, and aesthetic treatments. Dr. Faulkner received his medical degree from Tulane Medical School and went on to complete an internship in Internal Medicine, a residency in Ophthalmology, and a fellowship in Oculoplastics, Ocular Oncology, and Orbital Disease. Prior to establishing Aloha Laser Vision, Dr. Faulkner was a full-time Assistant Professor of Ophthalmology at Tulane. He maintains active membership in several professional organizations, including the American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgeons, and the International Society of Refractive Surgeons. He is available for interview upon request.

For more information about Dr. Faulkner and his practice, please visit alohalaservision.com and facebook.com/alohalaservision.

To view the original source of this press release, click here:  https://www.alohalaservision.com/news-room/honolulu-ophthalmologist-implants-first-visian-toric-icl-in-hawaii/

Aloha Laser Vision

1100 Ward Ave., Ste. 1000

Honolulu, Hawaii 96814

(808) 972-3937

Rosemont Media

(858) 200-0044

www.rosemontmedia.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/2cb65042-c364-4676-9022-4d47c01428d6

Aloha947392.jpg

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
18 Aug
VELO
Da flere skribenter stadig gerne vil beholde tråden for samling af de mange vigtige informationer o..
44
15 Aug
VELO
Det kunne tyde på at nogen mor modtaget receptal, der udviser netop det vi har talt om - at Envarsus..
37
19 Aug
OMXC25
Endnu en dansk patriark er død. Ære være hans minde.
27
18 Aug
 
Da Berlingske Media for cirka 1 år siden overtog Euroinvestor for 23 mio kr, meddelte de, at nu skul..
22
19 Aug
DANSKE
Min gud hvor er det røvkedeligt altid at skulle pløje igennem alt det personfnidder der er så meget ..
20
18 Aug
VELO
Fra anden skribent i Veloxis FB gruppen: Børsen side 4, søndag den 18. august. Et uddrag fra e..
20
20 Aug
VELO
Ny artikel på Medwatch:   15,5 pct. af amerikanske patienter, der får en nyretransplantation i dag, ..
17
20 Aug
PNDORA
  har du læst regnskabet - de forventer at tjene 4 mia i 2019 i forhold til en værdi af selskabet på..
17
19 Aug
OMXC25
En fantastisk dygtig og sympatisk erhvervsmand.  Og en ægte patriot som også betalte sin skat med gl..
17
16 Aug
I:NDX
16

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Rigrodsky & Long, P.A. Files Class Action Suit Against PCM, Inc.
2
Rigrodsky & Long, P.A. Files Class Action Suit Against WageWorks, Inc.
3
Start of Day Message
4
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CVS, GVA, IFF, PS, INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
5
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CAH, CARB, GTT, VNTR INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
21 August 2019 02:35:17
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB7 - 2019-08-21 03:35:17 - 2019-08-21 02:35:17 - 1000 - Website: OKAY